Project Details
Projekt Print View

The role of MALT1 in the molecular pathogenesis of mantle cell lymphoma

Subject Area Hematology, Oncology
Term from 2015 to 2019
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 279027844
 
Final Report Year 2020

Final Report Abstract

With a median age of 65 years at diagnosis, mantle cell lymphoma (MCL) is a disorder of the elderly. Although MCL accounts for only 8-10% of all malignant lymphoma cases, it contributes disproportionately to lymphoma mortality, due to its often aggressive clinical course and lack of curative therapeutic regimens. Despite recent advances in the understanding of the biology of MCL, many pathogenetic mechanisms and biologic features remain unknown. Within the funded project, we aimed to elucidate the role of the paracaspase MALT1 in the molecular pathogenesis of MCL. Here we show that a subset of MCLs is addicted to MALT1 signaling, as its inhibition by either RNA or pharmacologic interference induced cytotoxicity both in vitro and in vivo. Gene expression profiling following MALT1 inhibition demonstrated that MALT1 controls a MYC-driven gene expression network predominantly through increasing MYC protein stability. Thus, our analyses identify a previously unappreciated regulatory mechanism of MYC expression. MYC itself is pivotal for MCL survival as its downregulation and pharmacologic inhibition induced cytotoxicity in all MCL models. Collectively, these results provide a strong mechanistic rationale to investigate the therapeutic efficacy of targeting the MALT1-MYC axis in MCL patients.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung